biostudies-literatureUnknown114(5)Hosono NNext-generation sequencing of AML has identified specific genetic mutations in AML patients. Hematologic Malignancies (HM)-SCREEN-Japan 01 is a multicenter study to detect actionable mutations using paraffin-embedded bone marrow (BM) clot specimens rather than BM fluid in AML patients for whom standard treatment has not been established. The purpose of this study is to evaluate the presence of potentially therapeutic target gene mutations in patients with newly diagnosed unfit AML and relapsed/refractory AML (R/R-AML) using BM clot specimens. In this study, 188 patients were enrolled and targeted sequencing was undertaken on DNA from 437 genes and RNA from 265 genes. High-quality DNA and RNA were obtained using BM clot specimens, with genetic alterations successfully detected in 177 patienCancer science2098-2108https://www.ebi.ac.uk/biostudies/studies/S-EPMC10154825biostudies-literatureClinical utility of genomic profiling of AML using paraffin-embedded bone marrow clots: HM-SCREEN-Japan 01.PMC10154825Fukuhara SFukushima KHosono NKobayashi TOno TIzutsu KUsuki KShibayama HChi SKatagiri STakahashi NYuda JYamamoto KYamauchi TEguchi MMinami YYamauchi NMorishita TAll HM-SCREEN-Japan 01 InvestigatorsKuroda JKojima KOgasawara RAbutani HKondo TIyama SYoshimitsu MNakamura YYanada MIshitsuka KGotoh AUtsu YfalseClinical utility of genomic profiling of AML using paraffin-embedded bone marrow clots: HM-SCREEN-Japan 01.Next-generation sequencing of AML has identified specific genetic mutations in AML patients. Hematologic Malignancies (HM)-SCREEN-Japan 01 is a multicenter study to detect actionable mutations using paraffin-embedded bone marrow (BM) clot specimens rather than BM fluid in AML patients for whom standard treatment has not been established. The purpose of this study is to evaluate the presence of potentially therapeutic target gene mutations in patients with newly diagnosed unfit AML and relapsed/refractory AML (R/R-AML) using BM clot specimens. In this study, 188 patients were enrolled and targeted sequencing was undertaken on DNA from 437 genes and RNA from 265 genes. High-quality DNA and RNA were obtained using BM clot specimens, with genetic alterations successfully detected in 177 patien2023-01-01T00:00:00Z2023 May2025-04-05T00:11:39.071Z2025-04-05T00:11:39.071ZS-EPMC101548253679324810.1111/cas.15746